501 related articles for article (PubMed ID: 22000656)
1. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
[TBL] [Abstract][Full Text] [Related]
2. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
3. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
4. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
5. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
6. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
Stensland MD; Jacobson JG; Nyhuis A
J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
[TBL] [Abstract][Full Text] [Related]
7. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
[TBL] [Abstract][Full Text] [Related]
8. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
Sankaranarayanan J; Puumala SE
Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
11. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
13. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
14. Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective.
Nicholl D; Akhras KS; Diels J; Schadrack J
Curr Med Res Opin; 2010 Apr; 26(4):943-55. PubMed ID: 20163295
[TBL] [Abstract][Full Text] [Related]
15. Analysis of costs, length of stay, and utilization of emergency department services by frequent users: implications for health policy.
Ruger JP; Richter CJ; Spitznagel EL; Lewis LM
Acad Emerg Med; 2004 Dec; 11(12):1311-7. PubMed ID: 15576522
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.
Locklear JC; Alemayehu B; Brody RS; Chavoshi S; Tunceli O; Kern D; Earley WR
Clin Ther; 2013 Dec; 35(12):1923-32. PubMed ID: 24275622
[TBL] [Abstract][Full Text] [Related]
17. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
Silberstein SD; Feliu AL; Rupnow MF; Blount AC; Boccuzzi SJ
Headache; 2007 Apr; 47(4):500-10. PubMed ID: 17445099
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
20. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
Jackson J; Fernandes AW; Nelson W
Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]